Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Jan 15;273(Pt 2)(Pt 2):277-81.
doi: 10.1042/bj2730277.

Mechanism and control of degradation and resynthesis of adenylates in tumour cells

Affiliations

Mechanism and control of degradation and resynthesis of adenylates in tumour cells

Z Kovacević et al. Biochem J. .

Abstract

A comparative study revealed that Ehrlich ascites carcinoma (EAC) cells use glutamine plus inosine for regeneration of adenylates via the purine nucleotide cycle, whereas AS 30D hepatoma cells use adenosine instead. This observation can be correlated with the very low production of aspartate from glutamine in hepatoma cells. Although glucose is an important energy fuel for EAC, it cannot maintain a high enough level of adenylates unless glutamine is also present. Kinetic analysis of hydrolysis of ATP and ADP in the presence of rotenone suggests that deamination of AMP does not maintain a high enough ATP/ADP ratio and probably does not act as energy buffer after inhibition of cell respiration. It seems that, compared with normal cells, malignant cells have the ability for a very rapid regeneration of adenylates. It is proposed that instability of the adenine nucleotide pool, owing to frequent aerobic-anaerobic transitions, represents an essential feature of neoplasia, with profound impact on the whole metabolism of tumour cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Biol Chem. 1971 Mar 25;246(6):1607-17 - PubMed
    1. Biochem J. 1991 Jan 15;273(Pt 2):271-5 - PubMed
    1. Cancer Res. 1973 Nov;33(11):2825-9 - PubMed
    1. J Cell Physiol. 1974 Jun;83(3):425-35 - PubMed
    1. Cancer Res. 1976 Mar;36(3):1144-50 - PubMed

Publication types

MeSH terms

Grants and funding